# FDA Inspection 1277419 - Avista Pharma Solutions, Inc. dba Cambrex - July 03, 2025

Source: https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/8a4208ef-dcad-47c0-9bbd-2ab3cdc26b19
Source feed: FDA_Inspections

> FDA Inspection 1277419 for Avista Pharma Solutions, Inc. dba Cambrex on July 03, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277419
- Company Name: Avista Pharma Solutions, Inc. dba Cambrex
- Inspection Date: 2025-07-03
- Product Type: Human Drugs
- Office Name: Atlanta District Office

## Related Documents

- [FDA Inspection 1277419 - 2025-07-03](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/60242fd5-25b3-43a8-96f2-d82c2b2bb19d)
- [FDA Inspection 1128465 - 2020-07-17](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/ee45f26b-b044-435f-9d45-4363448c47de)
- [FDA Inspection 805222 - 2012-10-30](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/8c625197-6012-4859-8f23-fe97d16d6479)
- [FDA Inspection 636454 - 2009-10-09](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/b08d8093-c5a2-4add-801d-fda1b977fdca)

Company: https://www.keypedia.com/companies/avista-pharma-solutions-inc-dba-cambrex/56214bca-3cc9-496a-a019-aab43c351824

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7